Lifeward Posts $4.12 Q2 Loss Per Share, Deepening Cash Burn
LFWD sits 81% above its 52-week low of $4.14.
Summary
Lifeward reported a Q2 loss of $4.12 per share, a sharp deterioration from the prior quarter's already weak results. The company's market cap is only about $22 million, so a loss of this magnitude is highly material and signals continued heavy cash burn. This follows the Q1 10-Q that showed a 22% revenue decline and a going concern warning, and the recent convertible financing that was highly dilutive. The S-3 filed on August 3 to register resale of 2.07 million shares adds further dilution pressure. Traders will focus on whether the company can sustain operations without additional capital raises.
At the time of this announcement, LFWD was trading at $7.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.3M. The 52-week trading range was $4.14 to $10.56. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.